Anti-RHG19/ ARHGAP19 monoclonal antibody

Anti-RHG19/ ARHGAP19 antibody for FACS & in-vivo assay

Target products collectionGo to ARHGAP19/ARHGAP19 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1997-Ab-1/ GM-Tg-hg-MP1997-Ab-2Anti-Human ARHGAP19 monoclonal antibodyHuman
GM-Tg-rg-MP1997-Ab-1/ GM-Tg-rg-MP1997-Ab-2Anti-Rat ARHGAP19 monoclonal antibodyRat
GM-Tg-mg-MP1997-Ab-1/ GM-Tg-mg-MP1997-Ab-2Anti-Mouse ARHGAP19 monoclonal antibodyMouse
GM-Tg-cynog-MP1997-Ab-1/ GM-Tg-cynog-MP1997-Ab-2Anti-Cynomolgus/ Rhesus macaque ARHGAP19 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1997-Ab-1/ GM-Tg-felg-MP1997-Ab-2Anti-Feline ARHGAP19 monoclonal antibodyFeline
GM-Tg-cang-MP1997-Ab-1/ GM-Tg-cang-MP1997-Ab-2Anti-Canine ARHGAP19 monoclonal antibodyCanine
GM-Tg-bovg-MP1997-Ab-1/ GM-Tg-bovg-MP1997-Ab-2Anti-Bovine ARHGAP19 monoclonal antibodyBovine
GM-Tg-equg-MP1997-Ab-1/ GM-Tg-equg-MP1997-Ab-2Anti-Equine ARHGAP19 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1997-Ab-1/ GM-Tg-hg-MP1997-Ab-2; GM-Tg-rg-MP1997-Ab-1/ GM-Tg-rg-MP1997-Ab-2;
GM-Tg-mg-MP1997-Ab-1/ GM-Tg-mg-MP1997-Ab-2; GM-Tg-cynog-MP1997-Ab-1/ GM-Tg-cynog-MP1997-Ab-2;
GM-Tg-felg-MP1997-Ab-1/ GM-Tg-felg-MP1997-Ab-2; GM-Tg-cang-MP1997-Ab-1/ GM-Tg-cang-MP1997-Ab-2;
GM-Tg-bovg-MP1997-Ab-1/ GM-Tg-bovg-MP1997-Ab-2; GM-Tg-equg-MP1997-Ab-1/ GM-Tg-equg-MP1997-Ab-2
Products NameAnti-ARHGAP19 monoclonal antibody
Formatmab
Target NameARHGAP19
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ARHGAP19 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species RHG19/ ARHGAP19 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP001213human ARHGAP19 Lentivirus particle
    ORF Viral VectorpGMLP001213human ARHGAP19 Lentivirus plasmid
    ORF Viral VectorpGMLPm003973mouse Arhgap19 Lentivirus plasmid
    ORF Viral VectorvGMLPm003973mouse Arhgap19 Lentivirus particle


    Target information

    Target IDGM-MP1997
    Target NameARHGAP19
    Gene ID84986,71085,679082,705496,477784,101087427,526945,100070751
    Gene Symbol and Synonyms4933411B03Rik,ARHGAP19,mFLJ00368
    Uniprot AccessionQ14CB8
    Uniprot Entry NameRHG19_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000213390
    Target ClassificationN/A

    The target: ARHGAP19, gene name: ARHGAP19, also named as . Members of the ARHGAP family, such as ARHGAP19, encode negative regulators of Rho GTPases (see RHOA; MIM 165390), which are involved in cell migration, proliferation, and differentiation, actin remodeling, and G1 cell cycle progression (Lv et al., 2007 [PubMed 17454002]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.